• Select Article Type
  • Abstract Supplements
  • Blood Group Review
  • Call to Arms
  • Communications
  • Hypothesis
  • In Memoriam
  • Interview
  • Introduction
  • Letter to the Editor
  • Short Report
  • abstract
  • Abstracts
  • Article
  • book-review
  • case-report
  • case-study
  • Clinical Practice
  • Commentary
  • Conference Presentation
  • conference-report
  • congress-report
  • Correction
  • critical-appraisal
  • Editorial
  • Editorial Comment
  • Erratum
  • Events
  • in-memomoriam
  • Letter
  • Letter to Editor
  • mini-review
  • minireview
  • News
  • non-scientific
  • Obituary
  • original-paper
  • original-report
  • Original Research
  • Pictorial Review
  • Position Paper
  • Practice Report
  • Preface
  • Preliminary report
  • Product Review
  • rapid-communication
  • Report
  • research-article
  • Research Communicate
  • research-paper
  • Research Report
  • Review
  • review -article
  • review-article
  • review-paper
  • Review Paper
  • Sampling Methods
  • Scientific Commentary
  • serologic-method-review
  • short-communication
  • short-report
  • Student Essay
  • Varia
  • Welome
  • Select Journal
  • Immunohematology


review-article | 30-September-2021

The Cromer blood group system: an update

The Cromer blood group system antigens are carried on CD55 (also known as DAF), a molecule that continues to demonstrate increasing polymorphism. CD55 is an important regulatory protein within the complement cascade and has increasingly been shown to play a role in hemostasis. CD55 is one of a few blood group–carrying proteins that are attached to the red blood cell (RBC) membrane through a glycosylphosphatidylinositol (GPI) linkage, and thus the Cromer “null” (IFC‒, Inab) phenotype arises not

J.R. Storry, C. Lomas-Francis

Immunohematology, Volume 37 , ISSUE 3, 118–121

Article | 20-December-2020

Cromer-related blood group antigens and the glycosyl phosphatidylinositol-linked protein, decay-accelerating factor DAF (CD55)

Marion Reid

Immunohematology, Volume 6 , ISSUE 2, 27–29

Article | 14-October-2020

A gel microtyping system for diagnosis of paroxysmal nocturnal hemoglobinuria

lysis (MIRL [CD59]). We evaluated the diagnostic value of a simple hemagglutination test using the gel microtyping system by comparing it with lytic tests (the Ham test and the sucrose lysis test) and with flow cytometry (FC) assessment of expression of GPI-anchored proteins (CD59 and CD55). Examining 51 blood samples from 48 patients, we found that the gel test is useful as a screening test for PNH diagnosis and can replace the Ham test and the sucrose lysis test. The threshold of the gel test is

Barbara Zupanska, Irena Bogdanik, Hanna Pyl

Immunohematology, Volume 18 , ISSUE 1, 9–12

Article | 21-April-2020

Novel molecular basis of an Inab phenotype  

Kim Hue-Roye, Vivien E. Powell, Gita Patel, Debra Lane, Mariska Maguire, Amy Chung, Marion E. Reid

Immunohematology, Volume 21 , ISSUE 2, 53–55

Review | 21-April-2020

Review: Cromer and DAF: role in health and disease

Douglas M. Lublin

Immunohematology, Volume 21 , ISSUE 2, 39–47

Article | 28-April-2020

Persistent anti-Dra in two pregnancies

The Drori (Dra) antigen is one of the ten high-prevalence antigens of the Cromer blood system, which are carried on decayaccelerating factor (DAF, CD55). The Dr(a–) phenotype was first described in a 48-year-old Jewish woman from Bukhara. Her serum contained an antibody to a high-prevalence antigen named anti-Dra. Most known individuals with the Dr(a–) phenotype are Jews from the geographic area of Bukhara, but individuals from Japan have also been described. Antibodies in the

Naomi Rahimi-Levene, Abraham Kornberg, Gabriela Siegel, Valery Morozov, Eilat Shinar, Orna Asher, Cyril Levene, Vered Yahalom

Immunohematology, Volume 21 , ISSUE 3, 126–128

Article | 21-April-2020

Analysis of SERF in Thai blood donors

Poonsub Palacajornsuk, Kim Hue-Roye, Oytip Nathalang, Srisurang Tantimavanich, Sasitorn Bejrachandra, Marion Reid

Immunohematology, Volume 21 , ISSUE 2, 66–69

No Record Found..
Page Actions